New eye test for hydroxychloroquine damage
Part of Eyes & vision clinical trials.
This trial tests a new type of eye test (ERG) to detect early damage from hydroxychloroquine, a drug used for conditions like lupus and rheumatoid arthritis. If you take hydroxychloroquine or have never taken it, you might help find better ways to protect your vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- You have taken hydroxychloroquine for more than 5 years (or more than 1 year if you have high-risk factors like a high dose, kidney problems, or tamoxifen use)
- Or you have never taken hydroxychloroquine
- No significant eye problems like advanced cataracts, macular degeneration, glaucoma, or diabetes
- No recent eye surgery or infections
- Not taking certain medications like amiodarone or sildenafil
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye scan to check the health of the retina at the back of the eye in people who have been taking hydroxychloroquine (a medicine for autoimmune conditions) for at least a year. The goal is to see if the drug causes any early changes in the eye's blood vessels, so that problems can be caught early.
This study uses a special, high-detail eye imaging machine to take clear pictures of the outer retina. It may help researchers understand these eye conditions better, and how the eye images look when people have an outer retinal disease.
This study looks at how Plaquenil (hydroxychloroquine) can harm the retina (the eye’s light-sensing layer) and whether genetics affect who gets affected. You may help by sharing medical details and providing an eye-related blood sample so researchers can compare gene patterns to eye findings.
This trial is testing a new software tool that helps doctors see and assess different parts of the retina in eye scans. It aims to see how well the tool works in people with and without certain retina conditions.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
Hear when a new Hydroxychloroquine Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.